Objectives: To examine patterns of nicotine dependence, the value of the Fagerström Test for Nicotine Dependence (FTND) and its correlation with self-reported tobacco use and urinary cotinine concentrations among pregnant Indigenous women in Townsville.
Design, participants and setting: Cross-sectional study of 201 consecutive women who self-reported tobacco use at their first antenatal visit to Townsville Aboriginal and Islander Health Service (TAIHS) between 1 November 2005 and 31 October 2007. All smokers were to be assessed by FTND, and 108 women participating in the Tilly’s Tracks project (a randomised trial of an intervention to reduce smoking in pregnant Aboriginal and Torres Strait Islander women) were to have a comprehensive smoking history taken and urinary cotinine samples collected.
Results: Of 302 Indigenous women presenting to TAIHS, 201 (66.6%) identified as current tobacco users at their first antenatal visit; this proportion rose to 79.6% in women aged < 20 years. An FTND was completed for 152 women (75.6%), with a median score of 4, and 40.1% scoring 3 or less, indicating low levels of nicotine dependence. There were significant correlations between the FTND and number of cigarettes smoked (ρ = 0.56; P < 0.001) and urinary cotinine concentrations (ρ = 0.25; P = 0.030). Of those who provided comprehensive smoking histories, the median age of starting smoking was 15 years, with a median of two previous quit attempts; 71.4% reported partners who smoked and 27.3% reported smoking occurred inside the house.
Conclusion: The use of the FTND in Indigenous pregnant women may assess physical nicotine dependence, thus providing information that will help in preparing quit-smoking plans, including tailoring of pharmacological support to individual need. Quit-smoking programs that better address the behavioural and psychological aspects of smoking within the Indigenous community in Australia are needed.
- 1. Ivers RG. An evidence-based approach to planning tobacco interventions for Aboriginal people. Drug Alcohol Rev 2004; 23: 5-9.
- 2. Baker A, Ivers RG, Bowman J, et al. Where there’s smoke, there’s fire: high prevalence of smoking among some sub-populations and recommendations for intervention. Drug Alcohol Rev 2006; 25: 85-96.
- 3. Shiffman S. Reflections on smoking relapse research. Drug Alcohol Rev 2006; 25: 15-20.
- 4. Johnston V, Thomas D. Smoking behaviours in a remote Australian Indigenous community: the influence of family and other factors. Soc Sci Med 2008; 67: 1708-1716.
- 5. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict 1991; 86: 1119-1127.
- 6. Piper M, McCarthy D, Baker T. Assessing tobacco dependence: a guide to measure evaluation and selection. Nicotine Tob Res 2006; 8: 339-351.
- 7. Royal Australian College of General Practitioners. Smoking cessation guidelines for Australian general practice: Practice handbook 2004. Melbourne: RACGP, 2005.
- 8. Panaretto KS, Lee HM, Mitchell MR, et al. Impact of a collaborative shared antenatal care program for urban Indigenous women: prospective cohort study. Med J Aust 2005; 182: 514-519. <MJA full text>
- 9. Gilligan C, Sanson-Fisher R, Eades S, et al. Assessing the accuracy of self-reported smoking status among pregnant Aboriginal and Torres Strait Islander women using cotinine biochemical validation. Drug Alcohol Rev 2009. In press.
- 10. Ministerial Council on Drugs Strategy. National Drug Strategy. Aboriginal and Torres Strait Islander peoples complementary action plan 2003–2006. Background paper. Canberra: National Drug Strategy, 2003. (accessed Oct 2009). <MJA full text>
- 11. Royal Australian College of General Practitioners. SNAP: a population health guide to behavioural risk factors in general practice. Melbourne: RACGP, 2004.
- 12. van Schayck OC, Pinnock H, Ostrem A, et al. International Primary Care Respiratory Group consensus statement. Tackling the smoking epidemic – practical guidance for primary care. Prim Care Respir J 2008; 17: 185-193.
- 13. de Leon J, Diaz FJ, Becoña E, et al. Exploring brief measures of nicotine dependence for epidemiological surveys. Addict Behav 2003; 28: 1481-1486.
- 14. Ward K, Vander Weg M, Sell M, et al. Characteristics and correlates of quitting smoking among black and white low-income pregnant smokers. Am J Health Behav 2006; 30: 651-662.
- 15. Händel G, Hannöver W, Röske K, et al. Intention to change smoking in pregnant and postpartum women according to number of pregnancies. Eur J Public Health 2009; 19: 218-221.
- 16. Schroeder JR, Moolchan ET. Ethnic differences among adolescents seeking smoking cessation treatment: a structural analysis of responses on the Fagerström Test for Nicotine Dependence. Nicotine Tob Res 2007; 9: 137-145.
- 17. Ivers RG, Farrington M, Burns CB, et al. A study of the use of free nicotine patches by Indigenous people. Aust N Z J Public Health 2003; 27: 486-490.
- 18. Tang J, Law M, Wald N. How effective is nicotine replacement therapy in helping people to stop smoking? BMJ 1994; 308: 21-26.
- 19. Peters MJ, Morgan LC. The pharmacotherapy of smoking cessation. Med J Aust 2002; 176: 486-490. <MJA full text>
- 20. Haufroid V, Lison D. Urinary cotinine as a tobacco-smoke exposure index: a minireview. Int Arch Occup Environ Health 1998; 71: 162-168.
- 21. Dempsey D, Jacob Pr, Benowitz N. Accelerated metabolism of nicotine and cotinine in pregnant smokers. J Pharmacol Exp Ther 2002; 301: 594-598.
- 22. Pickett K, Rathouz P, Kasza K, et al. Self-reported smoking, cotinine levels, and patterns of smoking in pregnancy. Paediatr Perinat Epidemiol 2005; 19: 368-376.
- 23. Gorber S, Schofield-Hurwitz S, Hardt J, et al. The accuracy of self-reported smoking: a systematic review of the relationship between self-reported and cotinine-assessed smoking status. Nicotine Tob Res 2009; 11: 12-24.
- 24. Lawrence T, Aveyard P, Croghan E. What happens to women’s self-reported cigarette consumption and urinary cotinine levels in pregnancy? Addiction 2003; 98: 1315-1320.
Publication of your online response is subject to the Medical Journal of Australia's editorial discretion. You will be notified by email within five working days should your response be accepted.